(CNN)President Trump has been a cheerleader for the drug hydroxychloroquine, pointing in a tweet and in person to a French study as evidence that one particular drug combination might be “one of the biggest game changers in the history of medicine.” But now the medical society that published that French research has issued a statement saying the study “does not meet the Society’s expected standard.” Dr. Kevin Tracey, president and CEO of the Feinstein Institutes for Medical Research in New York City, gave an even more pointed assessment of the French research. “The study was a complete failure,” he said. “It was pathetic,” added Art Caplan, head of the division of medical ethics at the New York University School of Medicine. The small French study of 20 people found that taking hydroxychloroquine was associated with the “viral load reduction/disappearance in COVID-19 patients,” noting that the effect was “reinforced” with azithromycin, an antibiotic better known as a Z-pack. Tracey and Caplan pointed out that several patients who took the drug, and ended up faring poorly, dropped out of the trial, and their outcomes were not factored into the study’s final conclusions. The International Society of Antimicrobial Chemotherapy published the study online


Continue To Full Article